For instance, MKI67 is a potential indicator to predict the prognosis of patients with stomach cancer and identify high-risk cases (Guo et al., 2018), and TYMS may be potential biomarkers for prognosis and chemotherapy guidance for stomach cancer (Cao et al., 2017). This evidence concerns the gene MKI67 and gastric neoplasm.